Add this topic to your myFT Digest for news straight to your inbox
Technique highlights concerns shifting global disease burden as populations age
High costs and concerns over efficacy and side effects limit uptake of first treatment as another nears approval
Research harnesses power of generative artificial intelligence in latest sign of its potential use in medicine
Study results could encourage US Medicare system and private insurers to cover tirzepatide treatments
UK research highlights risk of over-diagnosis and gaps in spotting serious variants of the disease
The idea that the technology might accelerate general human capabilities remains fanciful
Growing number of countries are also considering whether to amend legislation
Research forecasts global deaths from the disease will almost double in 20 years
It aims to exploit its extraordinary cache of genetic data but changing corporate DNA is hard
WHO member states are struggling to agree the terms of the first global treaty to deal with the threat of another Covid-19
Patients who took Sanofi’s lixisenatide experienced no worsening of motor symptoms
Not only is the cost-benefit ratio unbeatable, but not to undertake this spending is to court disaster
Chemotherapy can target microscopic cells to prevent the disease from spreading
Four years after lockdowns began we are still learning about pandemic hangovers
Funding needed to drive innovation and make therapies available to all, says co-discoverer Jennifer Doudna
Lenmeldy gene therapy treats MLD, a condition that attacks the central nervous system of young children
Ruth McKernan aims to make country a hub for research into the condition and accelerate development of new drugs
Officials warn weaknesses in surveillance will hinder vaccine development as countries struggle to agree accord
Worldwide study finds neurological conditions affect billions as life expectancy rises
Researchers use machine learning to discover that ‘junk DNA’ may play pivotal role in development of tumours
We risk forgetting the lessons of the Covid pandemic
Cultivation of stem cells extracted from amniotic fluid will help treat congenital conditions
New Pasteur Institute head highlights risks posed by shortages of money, staff and political goodwill
GHO Capital has put contract research group FairJourney Biologics up for sale
Research shows urgent need for policies to encourage weight loss and cut disease risk
International Edition